Elite Pharmaceuticals Inc  

(Public, OTCMKTS:ELTP)   Watch this stock  
Find more results for OTC:ELTP
0.245
+0.002 (0.82%)
Apr 24 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.23 - 0.25
52 week 0.17 - 0.51
Open 0.23
Vol / Avg. 1.91M/1.08M
Mkt cap 151.51M
P/E     -
Div/yield     -
EPS -0.11
Shares 618.41M
Beta 0.23
Inst. own 0%
Jun 29, 2015
Q4 2015 Elite Pharmaceuticals Inc Earnings Release (Estimated) Add to calendar
Feb 18, 2015
Q3 2015 Elite Pharmaceuticals Inc Earnings Call
Feb 17, 2015
Q3 2015 Elite Pharmaceuticals Inc Earnings Release
  

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 1542.06% -2098.83%
Operating margin -187.64% -114.83%
EBITD margin - -103.94%
Return on average assets 339.98% -544.96%
Return on average equity - -
Employees 38 -
CDP Score - -

Address

165 Ludlow Avenue
NORTHVALE, NJ 07647
United States - Map
+1-201-7502646 (Phone)
+1-201-7502755 (Fax)

Website links

Description

Elite Pharmaceuticals, Inc. (Elite) is a specialty pharmaceutical company principally engaged in the development and manufactures of oral, controlled-release products, using technology. Elite owns, licenses or contract manufactures eight products which are being sold commercially. These products are Phentermine 37.5 milligram tablets, Methadone 10 milligram tablets, Lodrane D Immediate Release capsules, Hydromorphone Hydrochloride 8 milligram tablets, Phendimetrazine tartrate 35 milligram tablets, Phentermine 15 milligram capsules, Phentermine 30 milligram capsules and Naltrexone HCl 50milligram tablets. The Company focuses on the development of various types of drug products, including branded drug products which require new drug applications. The Company offers both, branded and generic products in various therapeutic categories.

Officers and directors

Jerry I Treppel Chairman of the Board
Age: 60
Nasrat Hakim President, Chief Executive Officer, Director
Age: 53
Carter J. Ward CPA Chief Financial Officer, Treasurer, Secretary
Age: 50
Ashok G. Nigalaye Ph.D. Chief Scientific Officer, Director
Age: 62
Jeenarine Narine Director
Age: 64
Barry H. Dash Ph.D. Independent Director
Age: 83
Jeffrey A. Whitnell Independent Director
Age: 58